Corticosteroid withdrawal in kidney transplantation: the present status

Bibliography

• SAYEGH MH, CARPENTER CB: Transplantation 50 Years Later-Progress, Challenges and Promises. N. Engl. J. Med. (2004) 351:2761-2766.
   PubMed Web of Science ®Google Scholar
• BARNES PJ: Corticosteroids: the drugs to beat. Eur. J. Pharmacol. (2006) 533:2-14.
   PubMed Web of Science ®Google Scholar
• KARIN M: New Twists in Gene Regulation by Glucocorticoid Receptor: is DNA Binding Dispensable? Cell (1998) 93:487-490.
   PubMed Web of Science ®Google Scholar
• MURRAY JE, MERRILL JP, HARRISON JH, WILSON RE, DAMMIN GJ: Prolonged survival of human-kidney homografts by immunosuppressive drug therapy. N. Engl. J. Med. (1963) 268:1315-1323.
   PubMed Web of Science ®Google Scholar
• MEIER-KRIESCHE HU, SCHOLD JD, SRINIVAS TR, KAPLAN B: Lack of improvement in renal allograft survival despite a marked decrease in acute rejection rates over the most recent era. Am. J. Transplant. (2004) 4:378-383.
   PubMed Web of Science ®Google Scholar
• VINCENTI F: Immunosuppression minimization: current and future trends in transplant immunosuppression. J. Am. Soc. Nephrol. (2003) 14:1940-1948.
   PubMed Web of Science ®Google Scholar
• HRICIK DE: Steroid-free immunosuppression in kidney transplantation: an editorial review. Am. J. Transplant. (2002) 2:19-24.
   PubMed Web of Science ®Google Scholar
• GRINYO JM: Steroid sparing strategies in renal transplantation. Nephrol. Dialysis Transplantat. (2005) 20:2028-2031.
   PubMed Web of Science ®Google Scholar
• BUTTGEREIT F, BURMESTER GR, LIPWORTH BJ: Optimised glucocorticoid therapy: the sharpening of an old spear. Lancet (2005) 365:801-803.
   PubMed Web of Science ®Google Scholar
• VAN STAA TP, ABEDHAIM L, COOPER C, ZHANG B, LEUFKENS HGM: Public health impact of adverse bone effects of oral corticosteroids. Br. J. Clin. Pharmacol. (2001) 51:601-607.
   PubMed Web of Science ®Google Scholar
• LUKERT BP: Editorial: glucocorticoid replacement – how much is enough? J. Clin. Endocrinol. Metabol. (2006) 91:793-794.
   PubMed Web of Science ®Google Scholar
• MCKAY LI, CIDLOWSKI JA: Molecular control of immune/inflammatory responses: interaction between NF-κb and steroid receptor-signaling pathways. Endocri. Rev. (1999) 20:435-459.
   PubMed Web of Science ®Google Scholar
• KASISKE BL, SNYDER JJ, GILBERTSON D, MATAS AJ: Diabetes mellitus after kidney transplantation in the United States. Am. J. Transplant. (2003) 3:178-185.
   PubMed Web of Science ®Google Scholar
• KASISKE BL, COSIO FG, BETO J et al.: Clinical practice guidelines for managing dyslipidemias in kidney transplantation patients: a report from the managing dyslipidemias in chronic kidney disease work group of the national kidney foundation kidney disease outcomes quality initiative. Am. J. Transplant. (2004) 4:13-53.
   PubMed Web of Science ®Google Scholar
• EL-AMM JM, HARIRIAN A, CROOK ED: The effects of blood pressure and lipid control on kidney allograft outcome. Am. J. Cardiovasc. Drugs (2006) 6:1-7.
   PubMedGoogle Scholar
• CUNNINGHAM J: Posttransplantation bone disease. Transplantation (2005) 79:629-634.
   PubMed Web of Science ®Google Scholar
• HOLLANDER AA, HENE RJ, HERMANS J, VAN ES LA, VAN DER WOUDE FJ: Late prednisone withdrawal in cyclosporine-treated kidney transplant patients: a randomized study. J. Am. Soc. Nephrol. (1997) 8:294-301.
   PubMed Web of Science ®Google Scholar
• VAN DEN HAM ECH, KOOMAN JP, CHRISTIAANS MHL, VAN HOOFF JP: The influence if early steriod withdrawal of body composition and bone mineral density in renal transplant patients. Transplant. Intern. (2003) 16:82-87.
   PubMed Web of Science ®Google Scholar
• RADCLIFFE PJ, DUDLEY CRK, HIGINS RM, FIRTH JD, SMITH B, MORRIS PJ: Randomised Controlled trial of steroid withdrawal in renal transplant recipients receiving triple immunosuppression. Lancet (1996) 348:643-648.
   PubMed Web of Science ®Google Scholar
• HARADA H, MIURA M, OGAWA Y et al.: Late corticosteroid withdrawal can be safely performed for kidney recipients with stable graft function under pathological confirmation. Clin. Transplant. (2006) 20:26-32.
   PubMed Web of Science ®Google Scholar
• SMAK GREGOOR PJH, DE SEVAUX RGL, LIGTENBERG G et al.: Withdrawal of cyclosporine or prednisone six months after kidney transplantation in patients on triple drug therapy: a randomized, prospective, multicenter study. J. Am. Soc. Nephrol. (2002) 13:1365-1373.
   PubMed Web of Science ®Google Scholar
• LEMIEUX I, HOUDE I, PASCOT A et al.: Effects of prednisone withdrawal on the new metabolic triad in cyclosporine-treated kidney transplant patients. Kid. Int. (2002) 62:1839-1847.
   PubMed Web of Science ®Google Scholar
• OPELZ G, DOHLER B, LAUX G: Long-terms proscpective study of steroid withdrawal in kidney and heart transplant recipients. Am. J. Transplant. (2005) 5:720-728.
   PubMed Web of Science ®Google Scholar
• PELLETIER RP, AKIN B, FERGUSON RM: Prospective, randomized trial of steroid withdrawal in kidney recipients treated with mycophenolate mofetil and cyclosporine. Clin. Transplant. (2006) 20:10-18.
   PubMed Web of Science ®Google Scholar
• EL HAGGAN W, HURAULT DE LIGNY B, PARTIU A et al.: The evolution of weight and body composition in renal transplant recipients: two-year longitudinal study. Transplant Proc. (2006) 38:3517-3519.
   PubMed Web of Science ®Google Scholar
• AHSAN N, HRICIK DE, MATAS AJ et al.: Prednisone withdrawal in kidney transplant recipients on cyclosporin adn mycophenolate mofetil – a prospective randomized study. Steroid withdrawal study group. Transplantation (1999) 68:1865-1874.
   PubMed Web of Science ®Google Scholar
• HRICIK DE, KNAUSS TC, BODZIAK KA et al.: Withdrawal of steroid therapy in african american kidney transplant recipients receiving sirolimus and tacrolimus. Transplantation (2003) 76:938-942.
   PubMed Web of Science ®Google Scholar
• VANRENTERGHEM Y, VAN HOOFF JP, SQUIFFLET JP et al.: Minimization of immunosuppressive therapy after renal transplantation: results of a randomized controlled trial. Am. J. Transplant. (2005) 5:87-95.
   PubMed Web of Science ®Google Scholar
• PASCUAL J, VAN HOOFF JP, SALMELA K, LANG P, RIGOTTI P, BUDDE K: Three-year observational follow-up of a multicenter randomized trial on tacrolimus-based therapy with withdrawal of steroids or mycophenolate mofetil after renal transplantation. Transplantation (2006) 82:55-61.
   PubMed Web of Science ®Google Scholar
• BOOTS JMM, CHRISTIAANS MHL, VAN DUIJHOVEN EM, VAN SUYLEN RJ, VAN HOOFF JP: Early steroid withdrawal in renal transplantation with tacrolimus dual therapy: a pilot study. Transplantation (2002) 74:1703-1709.
   PubMed Web of Science ®Google Scholar
• MIDTVEDT K, HJELMESAETH J, HARTMANN A et al.: Insulin resistance after renal transplantation: the effect of steroid dose reduction and withdrawal. J. Am. Soc. Nephrol. (2004) 15:3233-3239.
   PubMed Web of Science ®Google Scholar
• FABREGA AJ, COHAN J, MESLAR P, POLLAK R: Effects of steroid withdrawal on long-term renal allograft recipients with post trasnplant diabetes mellitus. Surgery (1994) 116:792-797.
   PubMed Web of Science ®Google Scholar
• SARTORI M, PATRASSI G, RIGOTTI P et al.: Improved fibrinolytic capacity after withdrawal of steroid immunosuppression in renal transplant recipients. Transplantation (2000) 69:2116-2121.
   PubMed Web of Science ®Google Scholar
• FARMER CK, HAMPSON G, ABBS I et al.: Late low-dose steroid withdrawal in renal transplant recipients increases bone formation and bone mineral density. Am. J. Transplant. (2006) 6:2929-2936.
   PubMed Web of Science ®Google Scholar
• HAMIWKA LA, BURNS A, BELL L: Prednisone withdrawal in pediatric kidney transplant recipients on tacrolimus-based immunosuppression: four-year data. Pediatr. Transplant. (2006) 10:337-344.
   PubMed Web of Science ®Google Scholar
• AIKAWA A, MIYAGI M, MOTOYAMA O et al.: Pathological evaluation of steroid withdrawal in pediatric renal transplant recipients. Pediatr. Transplant. (1999) 3:131-138.
   PubMedGoogle Scholar
• PAINTER PL, TOPP KS, KRASNOFF JB et al.: Health-related fitness and quality of life following steroid withdrawal in renal transplant recipients. Kid. Int. (2003) 63:2309-2316.
   PubMed Web of Science ®Google Scholar
• ROGERS CC, ALLOWAY RR, BUELL JF et al.: Body weight alterations under early corticosteroid withdrawal and chronic corticosteroid therapy with modern immunosuppression. Transplantation (2005) 80:26-33.
   PubMed Web of Science ®Google Scholar
• ROSTAING L, CANTAROVICH D, MOURAD G et al.: Corticosteroid – free immunosuppression with tacrolimus, mycophenolate mofetil, and dacluzimab induction in renal transplantation. Transplantation (2005) 79:807-814.
   PubMed Web of Science ®Google Scholar
• KHWAJA K, ASOLATI M, HARMON J et al.: Outcome at 3 year with a prednisone – free maintenance regimen: a single center experince with 349 kidney transplant recipients. Am. J. Transplant. (2004) 4:980-987.
   PubMed Web of Science ®Google Scholar
• MATAS AJ, KANDASWAMY R, HUMAR A et al.: Long-term immunosuppression, without maintenance prednisone, after kidney transplantation. Annals Surg. (2004) 240:510-517.
   PubMed Web of Science ®Google Scholar
• HARIRIAN A, SILLIX DH, MORAWSKI K et al.: Short-term experience with early steroid withdrawal in African–American renal transplant recipients. Am. J. Transplant. (2006) 6:2396-2402.
   PubMed Web of Science ®Google Scholar
• VINCENTI F, SCHANA FP, PARASKEVAS S, HAUSER I, GRINYO J: Metabolic effects of steroid avoidance or early steroid withdrawal; at 12 month results of a randomized trial in de novo renal transplant patients receiving cyclosporine, enteric-coated mycophenolate sodium and basiliximab. Am. J. Transplant. (2006) 6(Suppl.):483.
   Google Scholar
• TAN JY, ZHAO N, WU TX et al.: Steroid withdrawal increases risk of acute rejection but reduces infection: a meta-analysis of 1681 cases in renal transplantation. Transplant. Proc. (2006) 38:2054-2056.
   PubMed Web of Science ®Google Scholar
• MIOZZARI M, AMBUHL PM: Steroid withdrawal after long-term medication for immunosuppressive therapy in renal transplant patients: adrenal response and clinical implications. Nephrol. Dial. Transplant. (2004) 19:2615-2621.
   PubMed Web of Science ®Google Scholar
• CATTANEO D, PERICO N, GASPARI F, GOTTI E, REMUZZI G: Glucocorticoids interfere with mycophenolate mofetil bioavailability in kidney transplantation. Kid. Int. (2002) 62:1060-1070.
   PubMed Web of Science ®Google Scholar
• VAN DUIJNHOVEN EM, BOOTS JMM, CHRISTIAANS MHL, STOLK LM, UNDRE NA, VAN HOOFF JP: Increase in tacrolimus levels after steroid withdrawal. Transplant. Intern. (2003) 16:721-725.
   PubMed Web of Science ®Google Scholar
• SCHULAK JA: Steroid immunosuppression in kidney transplantation: a passing era. J. Surgical Res. (2004) 117:154-162.
   PubMed Web of Science ®Google Scholar
• GRINYO JM, GIL-VERNET S, SERON D et al.: Steroid withdrawal in mycophenolate mofetil-treated renal allograft recipients. Transplantation (1997) 63:1688-1690.
   PubMed Web of Science ®Google Scholar
• VEENSTRA DL, BEST JH, HORNBERGER J, SULLIVAN SD, HRICIK DE: Incidence and long-term cost of steroid-related side effects after renal transplantation. Am. J. Kidney Dis. (1999) 33:829-839.
   PubMed Web of Science ®Google Scholar
• SIVARAMAN P, NUSSBAUMER G, LANDSBERG D: Lack of long-term benefits of steroid withdrawal in renal transplant recipients. Am. J. Kidney Dis. (2001) 37:1162-1169.
   PubMed Web of Science ®Google Scholar
• TER MEULEN CG, VAN RIEMSDIJK I, HENE RJ et al.: Steroid – withdrawal at 3 days after renal transplantation with anti-IL-2 receptor alpha therapy: a prospective, randomized, multi-center study. Am. J. Transplant. (2004) 4:803-810.
   PubMed Web of Science ®Google Scholar
• HRICIK DE, SCHULAK JA: Metabolic effects of steroids withdrawal in adult renal transplantation recipients. Kid. Int. (1993) 44:S26-S29.
   Web of Science ®Google Scholar
• KASISKE BL, CHAKKERA HA, LOUIS TA, MA JZ: A meta-analysis of immunosuppression withdrawal trials in renal transplantation. J. Am. Soc. Nephrol. (2000) 11:1910-1917.
   PubMed Web of Science ®Google Scholar
• SANFEY H, HAUSSMAN G, ISAACS I et al.: Steroid withdrawal in kidney transplant recipients: is it a safe option? Clin. Transplant. (1997) 11:500-504.
   PubMed Web of Science ®Google Scholar
• SANDRINI S, MAIORCA R, SCOLARI F et al.: A prospective randomized trial of azathioprine addition to cyclosporine versus cyclosporin monotherapy at steroid withdrawal, 6 months after renal transplantation. Transplantation (2000) 69:1861-1867.
   PubMed Web of Science ®Google Scholar
• KUYPERS DR, EVENEPOEL P, MAES B, COOSEMANS W, PIRENNE J, VANRENTERGHEM Y: The use of an anti-CD25 monoclonal antibody and mycophenolate mofetil enables the use of a low-dose tacrolimusand early withdrawal for steroids in renal transplant patients. Clin. Transplant. (2003) 17:234-241.
   PubMed Web of Science ®Google Scholar
• PARK JB, KIM SJ, OH HY et al.: Steroid withdrawal in living donor renal transplant recipients using tacrolimus and cyclosporine: a randomized prospective study. Transplant. Intern. (2006) 19:478-484.
   PubMed Web of Science ®Google Scholar
• WLODARCZYK Z, WALASZEWSKI J, PERNER F et al.: Freedom from rejection and stable kidney function are excellent criteria for steroid withdrawal in tacrolimus-treated kidney transplant recipients. Ann. Transplant. (2002) 7:28-31.
   PubMedGoogle Scholar
• WLODARCZYK Z, WALASZEWSKI J, PERNER F et al.: Steroid withdrawal at 3 months after kidney transplantation: a comparison of two tacrolimus-based regimens. Transplant. Int. (2005) 18:157-162.
   PubMed Web of Science ®Google Scholar
• PASCUAL J, QUEREDA C, ZAMORA J, HERNANDEZ D: Steroid withdrawal in renal transplant patients on triple therapy with a calcineurin inhibitor and mycophenolate mofetil: a meta-analysis of randomized, controlled trials. Transplantation (2004) 78:1548-1556.
   PubMed Web of Science ®Google Scholar
• PASCUAL J, QUEREDA C, ZAMORA J, HERNANDEZ D: Updated meta-analysis of steroid withdrawal in renal transplant patients on calcineurin inhibitor and mycophenolate mofetil. Transplant. Proc. (2005) 37:3746-3748.
   PubMed Web of Science ®Google Scholar
• RAMA I, CRUZADO JM, GIL-VERNET S et al.: Steroids can be safely withdrawn from cyclosporine and mycophenolate mofetil-treated renal allograft recipients: long-term results. Transplantation (2005) 80:164-168.
   PubMed Web of Science ®Google Scholar
• LAOUAD I, HALIMI JM, BUCHLER M et al.: Recipient age and mycophenolate mofetile as the main determinants of outcome after steroid withdrawal: analysis of long-term follow-up in renal transplantation. Transplantation (2005) 80:872-874.
   PubMed Web of Science ®Google Scholar
• VILA A, RICART MJ, VILARDELL JV et al.: Late steroid withdrawal in kidney transplant recipients. Transplant. Proc. (2000) 32:2634-2635.
   PubMed Web of Science ®Google Scholar
• HRICIK DE, AUGUSTINE JJ, KNAUSS TC et al.: Long-term graft outcomes after steroid withdrawal in African American kidney transplant recipients receiving sirolimus and tacrolimus. Transplantation (2007) 83:277-281.
   PubMed Web of Science ®Google Scholar
• KHWAJA K, ASOLATI M, HARMON J et al.: Rapid discontinuation of prednisone in higher-risk kidney transplant recipients. Transplantation (2004) 78:1397-1399.
   PubMed Web of Science ®Google Scholar
• BORROWS R, LOUCAIDOU M, VAN TROMP J et al.: Steroid sparing with tacrolimus and mycophenolate mofetil in renal transplantation. Am. J. Transplant. (2004) 4:1845-1851.
   PubMed Web of Science ®Google Scholar
• WOODLE ES, VINCENTI F, LORBER MI et al.: A multi-center pilot study of early (4 day) steroid cessation in renal transplant recipients under simulect, tacrolimus and sirolimus. Am. J. Transplant. (2005) 5:157-166.
   PubMed Web of Science ®Google Scholar
• LAFTAVI MR, STEPHEN R, STEFANICK B et al.: Randomized prospective trial of early steroid withdrawal compared with low-dose steroids in renal transplant recipients using serial protocol biopsies to assess efficacy and safety. Surgery (2005) 137:364-371.
   PubMed Web of Science ®Google Scholar
• KUMAR A: Safety and efficacy of steroid withdrawal two days after kidney transplantation: analysis of results at three years. Transplantation (2006) 83:277-281.
   Web of Science ®Google Scholar
• ANIL KUMAR MS, MORITZ MJ, SAAED MI et al.: Avoidance of chronic steroid therapy in African American kidney transplant recipients monitored by surveillance biopsy: 1-year results. Am. J. Transplant. (2005) 5:1976-1985.
   PubMed Web of Science ®Google Scholar
• HEILMAN RL, REDDY KS, MAZUR MJ et al.: Acute rejection risk of kidney transplant recipients on steroid-avoidance immunosuppression receiving induction with either antithymocyte globulin or basiliximab. Transplant. Proc. (2006) 38:1307-1313.
   PubMed Web of Science ®Google Scholar
• RAJAB A, PELLETIER RP, HENRY ML, FERGUSON RM: Excellent clinical outcomes in primary kidney transplantation recipients treated with steroid-free maintenance immunosuppression. Clin. Transplant. (2006) 20:537-546.
   PubMed Web of Science ®Google Scholar
• WOODLE ES: A randomized double blind placebo controlled trial of early corticosteroid cessation versus chronic corticosteroids: 3 years' results. Am. J. Transplant. (2006) 6(Suppl.):177.
   Google Scholar
• SCHANA FP, VINCENTI F, PARASKEVAS S, HAUSER I, GRINYO J: 12-Month results of a prospective randomized trial of steroid avoidance, steroid withdrawal and standard steroids in de novo renal transplant patients receiving cyclosporine, enteric-coded mycophenolate sodium and basiliximab. Am. J. Transplant. (2006) 6(Suppl.):84.
   Google Scholar
• BIRKELAND SA: Steroid-free immunosuppression in renal transplantation: a long-term follow-up of 100 consecutive patients. Transplantation (2001) 71:1089-1090.
   PubMed Web of Science ®Google Scholar
• BIRKELAND SA: Steroid-free immunosuppression after kidney transplantation with antithymocyte globulin induction and cyclosporine and mycophenolate mofetil maintenance therapy. Clin. Transplant. (1998) 66:1207-1210.
   Web of Science ®Google Scholar
• COLE E, LANDSBERG D, RUSSELL D et al.: A pilot study if steroid-free immunosuppression in the prevention of acute rejection in renal allograft recipients. Transplantation (2001) 72:845-850.
   PubMed Web of Science ®Google Scholar
• YOUNG CJ, GASTON RA: Renal transplantation in black Americans. N. Engl. J. Med. (2000) 343:1545-1552.
   PubMed Web of Science ®Google Scholar
• BOARDMAN R, ALLOWAY RR, ALEXANDER JW et al.: African-American renal transplant recipients benefit from early corticosteroid withdrawal under modern immunosuppression. Am. J. Transplant. (2004) 5:356-365.
   Web of Science ®Google Scholar
• CIANCIO G, BURKE GW, GAYNOR JJ et al.: The use of campath-1 has induction therapy in renal transplantation: preliminary results. Transplantation (2004) 78:426-433.
   PubMed Web of Science ®Google Scholar
• TAN HP, KACZOROWSKI DJ, BASU A et al.: Living donor renal transplantation using alemtuzumab induction and tacrolimus monotherapy. Am. J. Transplant. (2006) 6:2409-2417.
   PubMed Web of Science ®Google Scholar